These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25317574)

  • 1. A call for accurate pharmacogenetic labeling: telling it like it is.
    Burke W; Thummel K
    JAMA Intern Med; 2014 Dec; 174(12):1945-6. PubMed ID: 25317574
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels.
    Wang B; Canestaro WJ; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1938-44. PubMed ID: 25317785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardize units for dosing liquid oral prescription medicines, task group says.
    Traynor K
    Am J Health Syst Pharm; 2014 Jul; 71(13):1062-4. PubMed ID: 24939491
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs.
    Vivot A; Boutron I; Ravaud P; Porcher R
    Genet Med; 2015 Sep; 17(9):733-8. PubMed ID: 25521333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some patients may receive too much information about prescriptions.
    Lavine G
    Am J Health Syst Pharm; 2009 Apr; 66(8):696-7. PubMed ID: 19336824
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of the parenteral nutrition use process.
    Boullata JI
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):10S-13S. PubMed ID: 22275321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized medicine: is it a pharmacogenetic mirage?
    Shah RR; Shah DR
    Br J Clin Pharmacol; 2012 Oct; 74(4):698-721. PubMed ID: 22591598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities and differences between US and Japan as to pharmacogenomic biomarker information in drug labels.
    Otsubo Y; Asahina Y; Noguchi A; Sato Y; Ando Y; Uyama Y
    Drug Metab Pharmacokinet; 2012; 27(1):142-9. PubMed ID: 22201121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encouraging pharmacist intervention and standardization of labeling and dispensing of oral liquid medications.
    Endriukaitis LA; Briars LA; Bursua AJ
    J Am Pharm Assoc (2003); 2017; 57(3):412-413. PubMed ID: 28506399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists and patients feedback on empirically designed prescription warning labels: a qualitative study.
    Shiyanbola OO; Smith PD; Huang YM; Mansukhani SG
    Int J Clin Pharm; 2017 Feb; 39(1):187-195. PubMed ID: 28070688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Nutrient Content and Other Label Information for Prescription Prenatal Supplements Different from Nonprescription Products?
    Saldanha LG; Dwyer JT; Andrews KW; Brown LL; Costello RB; Ershow AG; Gusev PA; Hardy CJ; Pehrsson PR
    J Acad Nutr Diet; 2017 Sep; 117(9):1429-1436. PubMed ID: 28571654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine.
    Mehta D; Uber R; Ingle T; Li C; Liu Z; Thakkar S; Ning B; Wu L; Yang J; Harris S; Zhou G; Xu J; Tong W; Lesko L; Fang H
    Drug Discov Today; 2020 May; 25(5):813-820. PubMed ID: 32032705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of genetic testing in patients prescribed drugs with pharmacogenomic information in FDA-approved labeling.
    Young J; Bhattacharya K; Ramachandran S; Lee A; Bentley JP
    Pharmacogenomics J; 2021 Jun; 21(3):318-325. PubMed ID: 33589791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies.
    Chambers JD; Pope EF; Wilkinson CL; Neumann PJ
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1240-1246. PubMed ID: 30479201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalizing medicine with clinical pharmacogenetics.
    Scott SA
    Genet Med; 2011 Dec; 13(12):987-95. PubMed ID: 22095251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic tests: the need for a level playing field.
    Pirmohamed M; Hughes DA
    Nat Rev Drug Discov; 2013 Jan; 12(1):3-4. PubMed ID: 23274456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translation of pharmacogenetic knowledge into cancer therapeutics.
    Yong WP; Innocenti F
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):698-706. PubMed ID: 17982411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.
    Reis-Pardal J; Rodrigues A; Rodrigues E; Fernandez-Llimos F
    Pharmacogenomics J; 2017 Dec; 17(6):488-493. PubMed ID: 27241061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Pharmacogenetic Information in Food and Drug Administration Drug Labeling and the Table of Pharmacogenetic Associations.
    Cheng CM; So TW; Bubp JL
    Ann Pharmacother; 2021 Oct; 55(10):1185-1194. PubMed ID: 33384014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.